The role of mu-opioid receptor signaling in the dorsolateral periaqueductal gray on conditional and unconditional responding to threatening and aversive stimuli

Neuroscience

Volumn 216, Issue , 2012, Pages 82-93

  Halladay, L R ^a   Blair, H T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fear conditioning; Morphine; Naltrexone; Opioids; Periaqueductal gray

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; NALTREXONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; AVERSION; BODY MOVEMENT; CANNULATION; CONDITIONING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; EVOKED AUDITORY RESPONSE; EYELID REFLEX; FEAR; HABITUATION; HISTOPATHOLOGY; LEARNING; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; SUPERIOR COLLICULUS; THREAT; UNCONDITIONAL RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); FEAR; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PERIAQUEDUCTAL GRAY; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION;

EID: 84862027179     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.04.045     Document Type: Article

References (72)

1. Anseloni V.C.Z., Coimbra N.C., Morato S., Brandao M.L. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test. Exp Brain Res 1999, 129:260-268.
2. Bandler R., Depaulis A., Vergnes M. Identification of midbrain neurons mediating defensive behaviour in the rat by microinjections of excitatory amino acids. Behav Brain Res 1985, 15:107-119.
3. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984, 7:309-338.
4. Blair H.T., Sotres-Bayon F., Moita M.A., Ledoux J.E. The lateral amygdala processes the value of conditioned and unconditioned aversive stimuli. Neuroscience 2005, 133:561-569.
5. Blanchard D.C., Blanchard R.J. Passive and active reactions to fear-eliciting stimuli. J Comp Physiol Psychol 1969, 68:129-135.
6. Bolles R.C., Fanselow M.S. A perceptual-defensive-recuperative model of fear and pain. Behav Brain Sci 1980, 3:291-323.
7. A receptors in the dorsal periaqueductal gray. Brain Res 2005, 1051:100-111.
8. Borges P.C., Coimbra N.C., Brandao M.L. Independence of aversive and pain mechanisms in the dorsal periaqueductal gray matter of the rat. Braz J Med Biol Res 1988, 21:1027-1031.
9. Brandao M.L., Anseloni V.Z., Pandossio J.E., De Araujo J.E., Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci Biobehav Rev 1999, 23:863-875.
10. Brandao M.L., Borelli K.G., Nobre M.J., Santos J.M., Albrechet-Souza L., Oliviera A.R., Martinez R.C. Gabaergic regulation of the neural organization of fear in the midbrain tectum. Neurosci Biobehav Rev 2005, 29:1299-1311.
11. Brandao M.L., Coimbra N.C., Borges P.C. Effects of morphine and midazolam on reactivity to peripheral noxious and central aversive stimuli. Neurosci Biobehav Res 1990, 14:495-499.
12. Brandao M.L., de Aguiar J.C., Graeff F.G. GABA mediation of the anti-aversive action of minor tranquilizers. Pharmacol Biochem Behav 1982, 16:397-402.
13. Breuker E., Dingledine R., Iversen L.L. Evidence for naloxone and opiates as GABA antagonists [proceedings]. Br J Pharmacol 1976, 58:458.
14. Brodsky M., Elliot K., Hynansky A., Jenab S., Inturrisi C.E. Quantitation of mu-opioid receptor (MOR-1) mRNA in selected regions of the rat CNS. Neuroreport 1995, 6:725-729.
15. Brown K.J., Grunberg N.E. Effects of housing on male and female rats: crowding stresses male but calms females. Physiol Behav 1995, 58:1085-1089.
16. Castilho V.M., Macedo C.E., Brandao M.L. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats. Psychopharmacology (Berlin) 2002, 165:77-85.
17. Coimbra N.C., Brandao M.L. Effects of 5-HT2 receptors blockade on fear induced analgesia elicited by electrical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray. Behav Brain Res 1997, 87:97-103.
18. Craft R.M., Clark J.L., Hart S.P., Pinckney M.K. Sex differences in locomotor effects of morphine in the rat. Pharmacol Biochem Behav 2006, 85:850-858.
19. Crane S.M., Shen K.F. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci USA 1995, 92:10540-10544.
20. Crane S.M., Shen K.F. GM1 ganglioside-induced modulation of opioid receptor-mediated functions. Ann NY Acad Sci 1998, 845:106-125.
21. Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992, 5:353-375.
22. De Luca M.C., Brandao M.L., Motta V.A., Landeira-Fernandez J. Antinociception induced by stimulation of ventrolateral periaqueductal gray at the freezing threshold is regulated by opioid and 5-HT2A receptors as assessed by the tail-flick and formalin tests. Pharmacol Biochem Behav 2003, 75:459-466.
23. De Luca-Vinhas M.C.Z., Macedo C.E., Brandao M.L. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray. Pain 2006, 121:94-104.
24. De Ross J., Avila M.A., Ruggiero R.N., Nobre M.J., Brandao M.L., Castilho V.M. The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum. Behav Brain Res 2009, 204:140-146.
25. Depaulis A., Keay K.A., Bandler R. Longitudinal neuronal organization of defensive reactions in the midbrain periaqueductal gray region of the rat. Exp Brain Res 1992, 90:307-318.
26. Depaulis A., Vergnes M. Elicitation of intraspecific defensive behaviors in the rat by microinjection of pircrotoxin, a gamma-aminobutyric acid antagonist, into the midbrain periaqueductal gray matter. Brain Res 1986, 367:87-95.
27. De Oca B.M., DeCola J.P., Maren S., Fanselow M.S. Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci 1998, 18:3426-3432.
28. Dingledine R., Iversen L.L., Breuker E. Naloxone as a GABA antagonist; evidence from iontophoretic, receptor binding, and convulsant studies. Eur J Pharmacol 1978, 47:19-27.
29. Fanselow M.S. The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. The midbrain periaqueductal gray matter: functional, anatomical, and neurochemical organization 1991, 151-175. Plenum, New York. A. Depaulis, R. Bandler (Eds.).
30. Fanselow M.S., Sigmundi R.A. Species-specific danger signals, endogenous opioid analgesia, and defensive behavior. J Exp Psychol Anim Behav Process 1986, 12:301-309.
31. Fanselow M.S., Landeira-Fernandez J., DeCola J.P., Kim J.J. The immediate shock deficit and postshock analgesia: implications for the relationship between the analgesic CR and UR. Anim Learn Behav 1994, 22:72-76.
32. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 1999, 23:743-760.
33. Gan T.J., Ginsberg B., Glass P.S.A., Fortney J., Jhaveri R., Perno R. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997, 87:1075-1081.
34. Giordano A.L., Nock B., Cicero T.J. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu, and delta opioid receptors. J Pharm Exp Ther 1990, 255:536-540.
35. Giralt M., Armario A. Individual housing does not influence the adaptation of the pituitary-adrenal axis and other physiological variables to chronic stress in adult male rats. Physiol Behav 1989, 45:477-481.
36. Goodman R.R., Snyder S.H., Kuhar M.J., Young W.S. Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci USA 1980, 77:6239-6243.
37. Halladay L.R., Iniguez S.D., Furqan F., Previte M.C., Chisum A.M., Crawford C.A. Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats. Pharmacol Biochem Behav 2009, 92:190-196.
38. Hammer G.D., Kapp B.S. The effects of naloxone administered into the periaqueductal gray on shock-elicited freezing behavior in the rat. Behav Neural Biol 1986, 46:189-195.
39. Helmstetter F.J., Landeira-Fernandez J. Conditional hypoanalgesia is attenuated by naltrexone applied to the periaqueductal gray. Brain Res 1990, 537:88-92.
40. Joshi G.P., Duffy J., Chehade J., Wesevich J., Gajraj N., Johsnson E.R. Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia. Anesthesiology 1999, 90:1007-1011.
41. Kalinichev M., White D.A., Holtzman S.G. Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization. Psychopharmacology (Berl) 2004, 177:61-67.
42. Kim J.J., Rison R.A., Fanselow M.S. Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. Behav Neurosci 1993, 107:1093-1098.
43. Kluver H., Bucy P.C. Psychic blindness and other symptoms following bilateral temporal lobectomy in rhesus monkeys. Am J Physiol 1937, 119:352-353.
44. Kosterlitz H.W., Leslie F.M. Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors. Br J Pharmacol 1978, 64:607-614.
45. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988, 8:2517-2529.
46. LeDoux J.E., Cicchetti P., Xagoraris A., Romanski L.M. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci 1990, 4:1062-1069.
47. Leman S., Dielenberg R.A., Carrive P. Effect of dorsal periaqueductal gray lesion on cardiovascular and behavioral responses to contextual conditioned fear in rats. Behav Brain Res 2003, 143:169-176.
48. Manning B.H., Morgan M.J., Franklin K.B. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience 1994, 63:289-294.
49. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci 1988, 11:308-314.
50. McNally G.P., Pigg M., Weidemann G. Opioid receptors in the midbrain periaqueductal gray regulate extinction of pavlovian fear conditioning. J Neurosci 2004, 24:6912-6919.
51. Morgan M.M., Whitney P.K., Gold M.S. Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray. Brain Res 1998, 31:159-166.
52. Moita M.A., Rosis S., Zhou Y., LeDoux J.E., Blair H.T. Hippocampal place cells acquire location-specific responses to the conditioned stimulus during auditory fear conditioning. Neuron 2003, 37:485-497.
53. Moita M.A., Rosis S., Zhou Y., LeDoux J.E., Blair H.T. Putting fear in its place. remapping of hippocampal place cells during fear conditioning. J Neurosci 2004, 24:7015-7023.
54. Motta V., Brandao M.L. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol Biochem Behav 1993, 44:119-125.
55. Morgan M.M., Clayton C.C. Defensive behaviors evoked from the ventrolateral periaqueductal gray of the rat: comparison of opioid and GABA disinhibition. Behav Brain Res 2005, 164:61-66.
56. Parsons C.G., West D.C., Headley P.M. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration. Br J Pharmacol 1989, 98:533-543.
57. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, California. 4th ed.
58. Pert A., Yaksh T. Localization of the antinociceptive action of morphine in primate brain. Pharmacol Biochem Behav 1975, 3:133-138.
59. Powell K.J., Abul-Husn N.S., Jhamandas A., Olmstead M.C., Beninger R.J., Jhamandas K. Paradoxical effects of the opioid antagonist naltrexone on morphine, analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 2002, 300:588-596.
60. Sante A.B., Nobre M.J., Brandao M.L. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol 2000, 11:583-589.
61. Seymour B., Dolan R. Emotion, decision making, and the amygdala. Neuron 2008, 58:662-671.
62. Shen K.F., Crain S.M. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res 1997, 757:176-190.
63. Simantov R., Snyder S.H. Morphine-like peptides, leucine enkephalin and methionine enkephalin: interactions with the opiate receptor. Mol Pharmacol 1976, 12:987-998.
64. Smith D.J., Perroti J.M., Crisp T., Cabral M.E., Long J.T., Scalzitti J.M. The mu opiate receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat brain. Eur J Pharmacol 1988, 156:47-54.
65. Tarpley J.W., Shlifer I.G., Halladay L.R., Blair H.T. Conditioned turning behavior: a Pavlovian fear response expressed during the post-encounter period following aversive stimulation. Neuroscience 2010, 169:1689-1704.
66. Terner J.M., Barrett A.C., Lomas L.M., Negus S.S., Picker M.J. Influence of low doses of naltrexone on morphine anticociception and morphine tolerance in male and female rats of four strains. Pain 2006, 122:90-101.
67. Vanderschuren L.J., Schoffelmeer A.N., Mulder A.H., DeVries T.J. Lack of cross-sensitization of the locomotor effects of morphine in amphetamine-treated rats. Neuropsychopharmacology 1999, 21:550-559.
68. Vianna D.M., Landeira-Fernandez J., Brandao M.L. Dorsolateral and ventral regions of the periaqueductal gray matter are involved in distinct types of fear. Neurosci Biobehav Rev 2001, 25:711-719.
69. Wang H.Y., Frankfurt M., Burns L.H. High-affinity naloxone binding to filamin A prevents mu opioid-receptor-Gs coupling underlying opioid tolerance and dependence. PLoS ONE 2008, 3:e1554.
70. Watkins L.R., Mayer D.J. Multiple endogenous opiate and non-opiate analgesia systems: evidence of their existence and clinical implications. Ann NY Acad Sci 1986, 467:273-299.
71. Weiskrantz L. Behavioral changes associated with ablation of the amygdaloid complex in monkeys. J Comp Physiol Psychol 1956, 49:381-391.
72. Yaksh T.L., Yeung J.C., Rudy T.A. Systematic examination in the rat brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res 1976, 10:83-103.